1. Home
  2. THRM vs ABCL Comparison

THRM vs ABCL Comparison

Compare THRM & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$38.75

Market Cap

1.1B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.39

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
ABCL
Founded
1991
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
THRM
ABCL
Price
$38.75
$4.39
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$39.00
$7.75
AVG Volume (30 Days)
169.4K
3.7M
Earning Date
02-18-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$1,468,728,000.00
$35,325,000.00
Revenue This Year
$3.56
$25.45
Revenue Next Year
$2.52
$10.07
P/E Ratio
$39.37
N/A
Revenue Growth
N/A
7.17
52 Week Low
$22.75
$1.89
52 Week High
$41.09
$6.52

Technical Indicators

Market Signals
Indicator
THRM
ABCL
Relative Strength Index (RSI) 58.14 68.43
Support Level $35.86 $3.34
Resistance Level $37.57 $4.20
Average True Range (ATR) 0.97 0.21
MACD 0.11 0.11
Stochastic Oscillator 71.55 87.55

Price Performance

Historical Comparison
THRM
ABCL

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: